The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 1×
“Alcohol dependence is a chronic relapsing medical disorder [2].”
BackgroundBiodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Self-citationNaltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Shank, R. P., Gardocki, J. F., Streeter, A. J., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02163.x · Cited by 810
Biodegradable polymers as drug delivery systems
(1992) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(92)90663-b · Cited by 779
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 759
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Self-citationPharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09932-8 · Cited by 665
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., Ehrich, E. W., & Vivitrex Study Group, F. T. (2005) · JAMA · doi:10.1001/jama.293.13.1617 · Cited by 635
Neural Mechanisms of Drug Reinforcementa
KOOB, G. F. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25966.x · Cited by 610
Animal Models of Alcoholism: Neurobiology of High Alcohol-Drinking Behavior in Rodents
McBride, W. J., & Li, T.-K. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i4.40 · Cited by 600
BLUNDELL, J. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90098-4 · Cited by 576
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Biodegradable polymers as drug delivery systems
(1991) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(91)90162-g · Cited by 514
Carmen, B., Angeles, M., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
Morphine-induced activation of A10 dopamine neurons in the rat
Gysling, K., & Wang, R. Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90913-7 · Cited by 491
Addolorato, G. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.504 · Cited by 481
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.1986.03380110055026 · Cited by 431
Matthews, R. T., & German, D. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90048-4 · Cited by 426
Blier, P., & De Montigny, C. (1987) · Synapse · doi:10.1002/syn.890010511 · Cited by 426
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 414
Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Prihoda, T. J., Bordnick, P. S., Ait-Daoud, N., & Hensler, J. (2000) · JAMA · doi:10.1001/jama.284.8.963 · Cited by 414
Self-citationNaltrexone and Alcohol Dependence: Role of Subject Compliance
Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411
Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., Kämpf, P., Stracke, R., Baehr, M., Naber, D., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.92 · Cited by 400
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
Kranzler, H. R., & Van Kirk, J. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02356.x · Cited by 390
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
HEILIG, M., & EGLI, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 377
Controlled release of bioactive agents from lactide/glycolide polymers
Lewis, D. H. (1990) · Drugs and the pharmaceutical sciences · Cited by 370
Disulfiram Treatment of Alcoholism
Chick, J., Gough, K., Falkowski, W., Kershaw, P., Hore, B., Mehta, B., Ritson, B., Ropner, R., & Torley, D. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.1.84 · Cited by 367
Mann, K., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 364
Fluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200024004 · Cited by 357
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00045-4 · Cited by 356
Costall, B., Domeney, A. M., Naylor, R. J., & Tyers, M. B. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11394.x · Cited by 355
Gibbs, J. W., Sombati, S., DeLorenzo, R. J., & Coulter, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02164.x · Cited by 348
Wang, L., Liu, J., Harvey-White, J., Zimmer, A., & Kunos, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336351100 · Cited by 340
WOLFFGRAMM, J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00131-c · Cited by 331
Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes
Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb06047.x · Cited by 316
Effect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308
mu-Opioid receptor knockout mice do not self-administer alcohol.
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · PubMed · Cited by 303
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02165.x · Cited by 300
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-j0002.2001 · Cited by 298
Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference
Froehlich, J. C., Harts, J., Lumeng, L., & Li, T.-K. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90174-g · Cited by 296
Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes
Spanagel, R., & Zieglgänsberger, W. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)89800-8 · Cited by 291
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.391 · Cited by 289
CDT, GGT, and AST As Markers of Alcohol Use: The WHO/ISBRA Collaborative Project
Conigrave, K. M., Degenhardt, L. J., Whitfield, J. B., Saunders, J. B., Helander, A., & Tabakoff, B. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200203000-00005 · Cited by 283
Hemby, S. E., Co, C., Koves, T. R., Smith, J. E., & Dworkin, S. I. (1997) · Psychopharmacology · doi:10.1007/s002130050365 · Cited by 283
Caillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280
Modulation of High‐Voltage–Activated Calcium Channels in Dentate Granule Cells by Topiramate
Zhang, X., Velumian, A. A., Jones, O. T., & Carlen, P. L. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02173.x · Cited by 276
Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
Spanagel, R., Hölter, S. M., Allingham, K., Landgraf, R., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00174-4 · Cited by 274
Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989) · Psychopharmacology · doi:10.1007/bf00442004 · Cited by 267
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub2 · Cited by 265
Beyer, A., Koch, T., Schröder, H., Schulz, S., & Höllt, V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02340.x · Cited by 258
Mason, B. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530340025025 · Cited by 257
Drug therapy for alcohol dependence
Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255 · cited 1×
“therapy, the clinical outcome is poor, with up to 70% of patients resuming drinking within one year [3,4].”
BackgroundNaltrexone-induced alterations in human ethanol intoxication
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254
The Neurobiology of Motivation and Reward
Stellar, J. R., & Stellar, E. (1985) · Springer eBooks · doi:10.1007/978-1-4615-8032-4 · Cited by 250
Wurtman, J. J., & Wurtman, R. J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90339-4 · Cited by 245
Age of Alcoholism Onset: I. Relationship to Psychopathology
Buydens-Branchey, L. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810030031004 · Cited by 244
Befort, K., Filliol, D., Décaillot, F. M., Gavériaux-Ruff, C., Hoehe, M. R., & Kieffer, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006352200 · Cited by 242
Gelernter, J., Kranzler, H., & Cubells, J. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000556 · Cited by 241
Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum
Rossetti, Z. L., & Carboni, S. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00344-k · Cited by 237
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley, D. V., Kadlec, K., & Sykora, K. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Fenfluramine and Fluoxetine Spare Protein Consumption While Suppressing Caloric Intake by Rats
Wurtman, J. J., & Wurtman, R. J. (1977) · Science · doi:10.1126/science.929195 · Cited by 229
Disulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 228
Weiss, F., Mitchiner, M., Bloom, F. E., & Koob, G. F. (1990) · Psychopharmacology · doi:10.1007/bf02244123 · Cited by 228
King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997) · Psychopharmacology · doi:10.1007/s002130050156 · Cited by 227
Sertraline Treatment for Alcohol Dependence: Interactive Effects of Medication and Alcoholic Subtype
Pettinati, H. M., Volpicelli, J. R., Kranzler, H. R., Luck, G., Rukstalis, M. R., & Cnaan, A. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200007000-00015 · Cited by 227
Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
Naranjo, C. A., Kadlec, K. E., Sanhueza, P., Woodley-Remus, D., & Sellers, E. M. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.62 · Cited by 224
Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers
Naranjo, C. A., Sellers, E. M., Roach, C. A., Woodley, D. V., Sanchez-Craig, M., & Sykora, K. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.46 · Cited by 222
Gryder, D. S., & Rogawski, M. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07069.2003 · Cited by 216
Importance of delta opioid receptors in maintaining high alcohol drinking
Froehlich, J. C., Zweifel, M., Harts, J., Lumeng, L., & Li, T. K. (1991) · Psychopharmacology · doi:10.1007/bf02244246 · Cited by 216
Kranzler, H. R., Burleson, J. A., Brown, J., & Babor, T. F. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01696.x · Cited by 213
Lovinger, D. M., & White, G. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12934-9 · Cited by 213
Imipramine Treatment of Alcoholics With Primary Depression: A Placebo-Controlled Clinical Trial
McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212
MASON, B., GOODMAN, A., CHABAC, S., & LEHERT, P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.002 · Cited by 212
Croop, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830240090013 · Cited by 211
Ability of Baclofen in Reducing Alcohol Intake and Withdrawal Severity: I???Preclinical Evidence
Colombo, G., Agabio, R., Carai, M. A. M., Lobina, C., Pani, M., Reali, R., Addolorato, G., & Gessa, G. L. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200001000-00010 · Cited by 208
FINNEY, J. W., HAHN, A. C., & MOOS, R. H. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911217733.x · Cited by 207
Predicting Treatment Response to Naltrexone: The Influence of Craving and Family History
Monterosso, J. R., Flannery, B. A., Pettinati, H. M., Oslin, D. W., Rukstalis, M., O'Brien, C. P., & Volpicelli, J. R. (2001) · The American Journal on Addictions · doi:10.1080/105504901750532148 · Cited by 206
Ability of Baclofen in Reducing Alcohol Craving and Intake: II???Preliminary Clinical Evidence
Addolorato, G., Caputo, F., Capristo, E., Colombo, G., Gessa, G. L., & Gasbarrini, G. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200001000-00011 · Cited by 203
Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action
De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005) · CNS Drugs · doi:10.2165/00023210-200519060-00004 · Cited by 201 · cited 1×
“Acamprosate’s principal neurochemical effects have been attributed to antagonism of NMDA glutamate receptors [83,84], which restores the balance between excitatory and inhibitory neurotransmission that is dysregulated following chronic alcohol consumption [85].”
BackgroundGelernter, J., Gueorguieva, R., Kranzler, H. R., Zhang, H., Cramer, J., Rosenheck, R., Krystal, J. H., & the VA Cooperative Study #425 Study Group (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00339.x · Cited by 200
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 191
Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence
Sellers, E. M., Toneatto, T., Romach, M. K., Somer, G. R., Sobell, L. C., & Sobell, M. B. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00054.x · Cited by 185
Boismare, F., Daoust, M., Moore, N., Saligaut, C., Lhuintre, J. P., Chretien, P., & Durlach, J. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80020-9 · Cited by 184
Inhibition of Transient and Persistent Na+ Current Fractions by the New Anticonvulsant Topiramate
Taverna, S., Sancini, G., Mantegazza, M., Franceschetti, S., & Avanzini, G. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38047-4 · Cited by 184
5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic
Lovinger, D. M. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00054-6 · Cited by 182
Acamprosate in alcohol dependence: how does it work?
LITTLETON, J. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 178
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s002130100909 · Cited by 175
Herrero, A. I., Del Olmo, N., González-Escalada, J. R., & Solı́s, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00171-x · Cited by 174
Neuropharmacological treatments for alcoholism: scientific basis and clinical findings
Johnson, B. A., & Ait-Daoud, N. (2000) · Psychopharmacology · doi:10.1007/s002130000371 · Cited by 172
Self-citationEconomidou, D., Mattioli, L., Cifani, C., Perfumi, M., Massi, M., Cuomo, V., Trabace, L., & Ciccocioppo, R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0199-9 · Cited by 170
Effect of Fluoxetine on Alcohol Consumption in Male Alcoholics
Gorelick, D. A., & Paredes, A. (1992) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb01373.x · Cited by 170
Kranzler, H. R., Wesson, D. R., Billot, L., & DrugAbuse Sciences Naltrexone Depot Study Group (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000130804.08397.29 · Cited by 169
Topiramate Blocks Kainate‐Evoked Cobalt Influx into Cultured Neurons
Skradski, S., & White, H. S. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02171.x · Cited by 168
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.
Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., & Lowenstam, I. (1986) · PubMed · Cited by 166
Dahchour, A., De Witte, P., Bolo, N., Nédélec, J.-F., Muzet, M., Durbin, P., & Macher, J.-P. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00016-x · Cited by 165
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 163
Johnson, B. A., Ait‐Daoud, N., Akhtar, F. Z., & Ma, J. Z. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.905 · Cited by 160
Self-citationZhang, H., Luο, X., Kranzler, H. R., Lappalainen, J., Yang, B., Krupitsky, E. M., Zvartau, E. E., & Gelernter, J. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl024 · Cited by 154
μ-Opioid Receptor Knockout Mice Do Not Self-Administer Alcohol
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39326-7 · Cited by 153
Alcohol Preference in the Rat: Reduction Following Depletion of Brain Serotonin
MYERS, R. D., & Veale, W. L. (1968) · Science · doi:10.1126/science.160.3835.1469 · Cited by 151
Fadda, F., GARAU, B., Marchei, F., Colombo, G., & Gessa, G. L. (1991) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045088 · Cited by 150
Jaffe, A. J., Rounsaville, B. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & O'Malley, S. S. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.5.1044 · Cited by 149
Basavarajappa, B. S., & Hungund, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720522.x · Cited by 145
Cippitelli, A., Bilbao, A., Hansson, A. C., del Arco, I., Sommer, W. H., Heilig, M. A., Massi, M., Bermúdez‐Silva, F. J., Navarro, M., Ciccocioppo, R., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04056.x · Cited by 144
Long and short alcohol deprivation: Effects on AA and P alcohol-preferring rats
Sinclair, J. D., & Li, T. (1989) · Alcohol · doi:10.1016/0741-8329(89)90059-1 · Cited by 143
Harris, B. R., Prendergast, M., Gibson, D. A., Rogers, D. T., Blanchard, J. A., Holley, R. C., Fu, M. C., Hart, S. R., Pedigo, N. W., & Littleton, J. M. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02484.x · Cited by 143
Buspirone in the Treatment of Alcoholic Patients
Bruno, F. (2010) · Psychopathology · doi:10.1159/000284626 · Cited by 139
Family History of Alcoholism in Violent Offenders and Impulsive Fire Setters
Linnoila, M. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070039006 · Cited by 139
Johnson, B. A. (2005) · CNS Drugs · doi:10.2165/00023210-200519100-00005 · Cited by 135
Self-citationNMDA Receptor Antagonism and the Ethanol Intoxication Signal
Krystal, J. H., Petrakis, I. L., Krupitsky, E. M., Schütz, C., Trevisan, L. A., & D’Souza, D. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.010 · Cited by 132
Effects of Ondansetron in Early‐ Versus Late‐Onset Alcoholics: A Prospective, Open‐Label Study
Kranzler, H. R., Pierucci‐Lagha, A., Feinn, R., & Hernández–Ávila, C. A. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000075547.77464.76 · Cited by 128
Murphy, J. M., Waller, M. B., Gatto, G. J. J., et al. (1988) · Alcohol · doi:10.1016/0741-8329(88)90066-3 · Cited by 125
Harris, B. R., Prendergast, M., Gibson, D. A., Rogers, D. T., Blanchard, J. A., Holley, R. C., Fu, M. C., Hart, S. R., Pedigo, N. W., & Littleton, J. M. (2002) · PubMed · doi:10.1097/01.alc.0000042011.99580.98 · Cited by 124
Experience of a "slip" among alcoholics treated with naltrexone or placebo
O’Malley, S. S., Jaffe, A. J., Rode, S., & Rounsaville, B. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.281 · Cited by 123
Marinelli, P. W., Quirion, R., & Gianoulakis, C. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1490-2 · Cited by 123
Effect of Memantine on Cue-Induced Alcohol Craving in Recovering Alcohol-Dependent Patients
Krupitsky, E. M., Neznanova, O., Masalov, D. V., Burakov, A. M., Didenko, T., Romanova, T. N., Tsoy, M., Bespalov, A., Slavina, T. Y., Grinenko, A. Y., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.519 · Cited by 119
Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
Naranjo, C. A., Poulos, C. X., Bremner, K. E., & Lanctôt, K. L. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.85 · Cited by 118
Sustained‐Release Naltrexone for Alcoholism Treatment: A Preliminary Study
Kranzler, H. R., Modesto‐Lowe, V., & Nuwayser, E. S. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03703.x · Cited by 118
Alcohol Aversion in the Rat: Behavioral Assessment of Noxious Drug Effects
Nachman, M., Lester, D., & Magnen, J. L. (1970) · Science · doi:10.1126/science.168.3936.1244 · Cited by 115
Acute effects of Naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice
Kamdar, N., Miller, S. A., Syed, Y. M., Bhayana, R., Gupta, T., & Rhodes, J. S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0711-5 · Cited by 111
Naltrexone Increases the Latency to Drink Alcohol in Social Drinkers
Davidson, D., Swift, R. M., & Fitz, E. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01679.x · Cited by 111
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
Mason, B. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00368-8 · Cited by 110
Lê, A. D., Poulos, C. X., Quan, B., & Chow, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90672-a · Cited by 110
Serotonin and Ethanol Preference
McBride, W. J., Murphy, J. M., Lumeng, L., & Li, T. (1989) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1678-5_10 · Cited by 109
Hagan, R. M., Jones, B. J., Jordan, C., & Tyers, M. B. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14685.x · Cited by 108
Gessa, G. L., Serra, S., VACCA, G., Carai, M. A. M., & Colombo, G. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh114 · Cited by 106
Heyser, C. J., Moc, K., & Koob, G. F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300175 · Cited by 106
Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats
Colombo, G., Serra, S., Brunetti, G., Vacca, G., Carai, M. A. M., & Gessa, G. L. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00333-2 · Cited by 106
A Pilot Double‐Blind Treatment Trial of Memantine for Alcohol Dependence
Evans, S. M., LEVIN, F. R., Brooks, D. J., & Garawi, F. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00360.x · Cited by 105
Family History of Alcoholism Influences Naltrexone-Induced Reduction in Alcohol Drinking
Krishnan‐Sarin, S., Krystal, J. H., Shi, J. M., Pittman, B. P., & O’Malley, S. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.018 · Cited by 105
Genetic Moderators of Naltrexone's Effects on Alcohol Cue Reactivity
McGeary, J. E., Monti, P. M., Rohsenow, D. J., Tidey, J. W., Swift, R. M., & Miranda, R. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00156.x · Cited by 105
Implication of the endogenous opioid system in excessive ethanol consumption
Gianoulakis, C., de Waele, J., & Thavundayil, J. (1996) · Alcohol · doi:10.1016/0741-8329(95)02035-7 · Cited by 103
de Fonseca, F. R., Roberts, A. J., Bilbao, A., Koob, G. F., & Navarro, M. (1999) · PubMed · Cited by 103
Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat
Spanagel, R., Putzke, J., Stefferl, A., Schöbitz, B., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00175-6 · Cited by 100
Sertraline Treatment of Co-occurring Alcohol Dependence and Major Depression
Kranzler, H. R., Mueller, T., Cornelius, J. R., Pettinati, H. M., Moak, D. H., Martin, P., Anthenelli, R. M., Brower, K. J., O’Malley, S. S., Mason, B. J., et al. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000194620.61868.35 · Cited by 99
Gewiss, M., Heidbreder, C. A., Opsomer, L., DURBIN, P., & Witte, P. D. (1991) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045093 · Cited by 98
Pharmacotherapies for Alcohol Problems: A Review of Research with Focus on Developments since 1991
Litten, R. Z., Allen, J., & Fertig, J. B. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05264.x · Cited by 98
Johnson, B. A., Campling, G. M., Griffiths, P., & Cowen, P. J. (1993) · Psychopharmacology · doi:10.1007/bf02247375 · Cited by 97
Self-citationHodge, C. W., Samson, H. H., Lewis, R. S., & Erickson, H. L. (1993) · Alcohol · doi:10.1016/0741-8329(93)90034-l · Cited by 94
Verheul, R., Lehert, P., Geerlings, P. J., Koeter, M. W. J., & van den Brink, W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1991-7 · Cited by 94
Marinelli, P. W., Quirion, R., & Gianoulakis, C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.047 · Cited by 90
Drug addiction and its treatment : nexus of neuroscience and behavior
Johnson, B. A., & Roache, J. D. (1997) · Cited by 89
Self-citationJohnson, B. A., Ait‐Daoud, N., & Prihoda, T. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02048.x · Cited by 89
Self-citationGrisel, J. E., Mogil, J. S., Grahame, N. J., Rubinstein, M., Belknap, J. K., Crabbe, J. C., & Low, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01384-0 · Cited by 88
Kabel, D., & Petty, F. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01686.x · Cited by 88
Buspirone attenuates volitional alcohol intake in the chronically drinking monkey
Collins, D. M., & Myers, R. D. (1987) · Alcohol · doi:10.1016/0741-8329(87)90060-7 · Cited by 87
Ritanserin in the treatment of alcohol dependence - a multi-center clinical trial
Johnson, B. A., Jasinski, D. R., Galloway, G. P., Kranzler, H. R., Weinreib, R., Anton, R. F., Mason, B. J., Bohn, M. J., Pettinati, H. M., Rawson, R. A., et al. (1996) · Psychopharmacology · doi:10.1007/s002130050126 · Cited by 86
Self-citationAcute effects of memantine in combination with alcohol in moderate drinkers
Bisaga, A. M., & Evans, S. M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1617-5 · Cited by 85
Serotonin Uptake Inhibitors Attenuate Ethanol Intake in Problem Drinkers
Naranjo, C. A., & Sellers, E. M. (1989) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1678-5_13 · Cited by 84
Effects of Acamprosate on Ethanol-Seeking and Self-Administration in the Rat
Czachowski, C. L., Legg, B. H., & Samson, H. H. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200103000-00005 · Cited by 84
Gianoulakis, C. (1998) · PubMed Central · Cited by 84
Serotonergic Agents and Alcoholism Treatment: Rebirth of the Subtype Concept???An Hypothesis
Johnson, B. A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04581.x · Cited by 83
Self-citationEffects of Acamprosate on Excitatory Amino Acids During Multiple Ethanol Withdrawal Periods
Dahchour, A., & Witte, P. D. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000056617.68874.18 · Cited by 82
Ethanol‐Related Behaviors in Serotonin Transporter Knockout Mice
Boyce‐Rustay, J. M., Wiedholz, L. M., Millstein, R. A., Carroll, J. C., Murphy, D. L., Daws, L. C., & Holmes, A. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00241.x · Cited by 82
Johnson, B. A., Ait‐Daoud, N., Aubin, H., van den Brink, W., Guzzetta, R. V., Loewy, J. W., Silverman, B. L., & Ehrich, E. W. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139823.30096.52 · Cited by 82
Self-citationTomkins, D. M., Lê, A. D., & Sellers, E. M. (1995) · Psychopharmacology · doi:10.1007/bf02246222 · Cited by 81
King, A. C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00416-x · Cited by 81
Pharmacologic approaches to the management of alcoholism.
Anton, R. F. (2001) · PubMed · Cited by 79
Johnson, B. A. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000134533.96915.08 · Cited by 79
Self-citationFoster, K. L., McKay, P. F., Seyoum, R., Milbourne, D., Yin, W., Sarma, P., Cook, J. M., & June, H. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300306 · Cited by 78
Serotonin Uptake Blockers and Voluntary Alcohol Consumption
Gill, K. J., & Amit, Z. (1989) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1678-5_12 · Cited by 77
Involvement of the serotonergic system in ethanol intake in the rat
Svensson, L., Fahlke, C., Hȧrd, E., & Engel, J. A. (1993) · Alcohol · doi:10.1016/0741-8329(93)90039-q · Cited by 77
Chick, J., Aschauer, H. N., & Hornik, K. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.012 · Cited by 77
Lovinger, D. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90131-7 · Cited by 76
Johnson, B. A., O’Malley, S. S., Ciraulo, D. A., Roache, J. D., Chambers, R. A., Sarid‐Segal, O., & Couper, D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084029.22282.bb · Cited by 76
Self-citationTreatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.
Dundon, W. D., Lynch, K., Pettinati, H., & Lipkin, C. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000130974.50563.04 · Cited by 75
Steffens, M., & Feuerstein, T. J. (2003) · Neurochemistry International · doi:10.1016/j.neuint.2003.08.009 · Cited by 75
Disulfiram effects on responses to intravenous cocaine administration
Baker, J. R., Jatlow, P. I., & McCance‐Katz, E. F. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.08.016 · Cited by 73
Powell, B. J., Campbell, J. L., Landon, J. F., Liskow, B. I., Thomas, H. M., Nickel, E. J., Dale, T. M., Penick, E. C., Samuelson, S. D., & Lacoursiere, R. B. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01532.x · Cited by 73
EFFECTS OF NALTREXONE ON THE ETHANOL-INDUCED CHANGES IN THE RAT CENTRAL DOPAMINERGIC SYSTEM
LEE, Y.-K. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh163 · Cited by 73
Role of sensory input in the control of food intake
Fantino, M. (1984) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(84)90032-8 · Cited by 71
Tzavara, E. T., Perry, K. W., Rodriguez, D. E., Bymaster, F. P., & Nomikos, G. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01228-6 · Cited by 71
Efficacy of Buspirone in Alcohol Dependence: A Review
Malec, T., Malec, E. A., & Dongier, M. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05263.x · Cited by 70
Moranta, D., Esteban, S., & Garc�a-Sevilla, J. A. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0921-x · Cited by 70
Biologic Correlates of Suicidal Risk and Aggressive Behavioral Traits
Linnoila, M., & Virkkunen, M. E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199204001-00004 · Cited by 69
Advances in development of medications for alcoholism treatment
Litten, R. Z., & Allen, J. P. (1998) · Psychopharmacology · doi:10.1007/s002130050686 · Cited by 66
Ooteman, W., Koeter, M. W. J., Verheul, R., Schippers, G. M., & van den Brink, W. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.012 · Cited by 65
Ondansetron alters human alcohol intoxication
Swift, R. M., Davidson, D., Whelihan, W. M., & Kuznetsov, O. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00432-7 · Cited by 62
Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
Chick, J., Lehert, P., & Landron, F. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174017 · Cited by 61
Naranjo, C. A., Bremner, K. E., & Lanctôt, K. L. (2003) · Addiction · doi:10.1046/j.1360-0443.1995.9018712.x · Cited by 59
Colombo, G., Vacca, G., Serra, S., Carai, M. A. M., & Gessa, G. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.069 · Cited by 57
Bromocriptine in the Treatment of Alcohol Dependence
Dongier, M., Vachon, L., & Schwartz, G. J. (1991) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb05197.x · Cited by 57
Krystal, J. H., Madonick, S. H., Perry, E. B., Gueorguieva, R. V., Brush, L., Wray, Y., Belger, A., & D’Souza, D. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300994 · Cited by 57
Gill, K. J., Amit, Z., & Koe, B. K. (1988) · Alcohol · doi:10.1016/0741-8329(88)90019-5 · Cited by 56
Heisler, L. K., Kanarek, R. B., & Homoleski, B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00021-0 · Cited by 55
The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal
Putzke, J., Spanagel, R., Tölle, T. R., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00696-6 · Cited by 55
Topiramate reduces ethanol consumption by C57BL/6 mice
Nguyen, S. A., Malcolm, R. J., & Middaugh, L. D. (2006) · Synapse · doi:10.1002/syn.20350 · Cited by 51
Research works printed but not linked: 30
- Resch, 2005, Glycyl-glutamine in nucleus accumbens reduces ethanol intake in alcohol preferring (P) rats, Brain Res, 1058, 73, 10.1016/j.brainres.2005.07.066 · doi:10.1016/j.brainres.2005.07.066
- Ross, 1976, Ethanol preference in the hamster: effects of morphine sulfate and naltrexone, a long-acting morphine antagonist, Proc West Pharmacol Soc, 19, 326
- Berman, 1984, Effects of naloxone on ethanol dependence in rats, Drug Alcohol Depend, 13, 245, 10.1016/0376-8716(84)90065-6 · doi:10.1016/0376-8716(84)90065-6
- Williams, 2004, Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic–pituitary–adrenal activity in rhesus monkeys, Alcohol Clin Exp Res, 28, 566, 10.1097/01.ALC.0000121655.48922.C4 · doi:10.1097/01.alc.0000121655.48922.c4
- Alim TN, Tai B, Chiang CN, Green T, Rosse RB, Lindquist T, et al. Tolerability study of a depot form of naltrexone substance abusers [abstract]. In: Harris LS, editor. Problems of drug dependence 1994: Proceedings of the 56th annual scientific meeting. vol. II. The College on Problems of Drug Dependence, Inc. NIDA Res Monogr 1995;153:253.
- Heishman SJ, Francis-Wood A, Keenan RM, Chiang CN, Terrill JB, Tai B, et al. Safety and pharmacokinetics of a new formulation of naltrexone [abstract]. In: Harris LS, editor. Problems of drug dependence 1993: Proceedings of the 55th annual scientific meeting. vol. II. The College on Problems of Drug Dependence, Inc. NIDA Res Monogr 1994;141:82.
- Biton, 2001, Topiramate titration and tolerability, Ann Pharmacother, 35, 173, 10.1345/aph.10093 · doi:10.1345/aph.10093 · Paper page
- Geller, 1973, Effects of para-chlorophenylalanine and 5-hydroxytryptophan on alcohol intake in the rat, Pharmacol Biochem Behav, 1, 361, 10.1016/0091-3057(73)90130-5 · doi:10.1016/0091-3057(73)90130-5
- Gill, 1988, A further examination of the effects of sertraline on voluntary ethanol consumption, Alcohol, 5, 355, 10.1016/0741-8329(88)90020-1 · doi:10.1016/0741-8329(88)90020-1
- Maurel, 1999, Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats, Alcohol, 17, 195, 10.1016/S0741-8329(98)00046-9 · doi:10.1016/s0741-8329(98)00046-9
- Gottfries, 1981, Influence of depression and antidepressants on weight, Acta Psychiatr Scand Suppl, 290, 353, 10.1111/j.1600-0447.1981.tb00739.x · doi:10.1111/j.1600-0447.1981.tb00739.x
- Simpson, 1981, Effect of zimelidine, a new antidepressant, on appetite and body weight, Br J Clin Pharmacol, 11, 96, 10.1111/j.1365-2125.1981.tb01112.x · doi:10.1111/j.1365-2125.1981.tb01112.x
- Li, 1983, 5-Hydroxytryptamine control of meal to meal composition chosen by rats, Fed Proc, 42, 542
- Heisler, 1997, Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats, Pharmacol Biochem Behav, 58, 767, 10.1016/S0091-3057(97)00036-1 · doi:10.1016/s0091-3057(97)00036-1
- Haraguchi, 1990, Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine, Pharmacol Biochem Behav, 35, 259, 10.1016/0091-3057(90)90236-B · doi:10.1016/0091-3057(90)90236-b
- Gulley, 1995, Selective serotonin reuptake inhibitors: effects of chronic treatment on ethanol-reinforced behavior in mice, Alcohol, 12, 177, 10.1016/0741-8329(94)00079-S · doi:10.1016/0741-8329(94)00079-s
- Meert, 1993, Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference, Alcohol Alcohol, 28, 157
- Meert, 1991, Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats, Pharmacopsychiatry, 24, 159, 10.1055/s-2007-1014461 · doi:10.1055/s-2007-1014461
- Myers, 1992, Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide, Pharmacol Biochem Behav, 43, 661, 10.1016/0091-3057(92)90392-S · doi:10.1016/0091-3057(92)90392-s
- Myers, 1998, Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats, Pharmacol Biochem Behav, 59, 91, 10.1016/S0091-3057(97)00330-4 · doi:10.1016/s0091-3057(97)00330-4
- Lankford, 1996, Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats, Alcohol, 13, 399, 10.1016/0741-8329(96)00061-4 · doi:10.1016/0741-8329(96)00061-4
- Zhou, 1996, Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells, J Pharmacol Exp Ther, 278, 732
- Lovinger, 1991, Inhibition of 5-HT3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells, J Neurophysiol, 66, 1329, 10.1152/jn.1991.66.4.1329 · doi:10.1152/jn.1991.66.4.1329
- Lovinger, 1991, Ethanol potentiates ion current mediated by 5-HT3 receptors on neuroblastoma cells and isolated neurons, Alcohol Alcohol Suppl, 1, 181
- Bradbury, 1985, Laterality of dopamine function and neuroleptic action in the amygdala in the rat, Neuropharmacology, 24, 1163, 10.1016/0028-3908(85)90149-2 · doi:10.1016/0028-3908(85)90149-2
- Eison, 1982, Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions, Science, 215, 188, 10.1126/science.6171884 · doi:10.1126/science.6171884
- Rodd-Henricks, 1999, Intracranial self-administration of ethanol into the posterior VTA of Wistar rats is mediated by 5-HT3 receptors [abstract], Alcohol Clin Exp Res, 23, 49A
- Sellers, 1992, Serotonin and alcohol drinking, NIDA Res Monogr, 119, 141
- Beardsley, 1994, Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats, Alcohol, 11, 389, 10.1016/0741-8329(94)90023-X · doi:10.1016/0741-8329(94)90023-x
- Naranjo, 1992, Novel neuropharmacological treatments of alcohol dependence, Clin Neuropharmacol, 15, 74A, 10.1097/00002826-199201001-00040 · doi:10.1097/00002826-199201001-00040
Cited by
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
A clinical perspective of obesity, metabolic syndrome and cardiovascular disease
Han, T. S., & Lean, M. E. (2016) · JRSM Cardiovascular Disease · doi:10.1177/2048004016633371 · Cited by 500
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 498
Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503
Dopaminergic reward system: a short integrative review
Arias-Carrión, O., Stamelou, M., Murillo-Rodríguez, E., Menéndez-González, M., & Pöppel, E. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-24 · Cited by 416
Metadata
- Authors
- Johnson, B. A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 75
- Issue
- 1
- Pages
- 34-56
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2082206299
- Cited by
- 264
- References
- 245
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.